Skandinaviska Enskilda Banken (SEB)
CVS icon

Skandinaviska Enskilda Banken (SEB)’s CVS Health CVS Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-833,771
Closed -$66.2M – 303
2025
Q4 		$66.2M Buy
833,771
+85,008
+11% +$6.7M 0.27% 71
2025
Q3 		$56.4M Sell
748,763
-7,656
-1% -$525K 0.23% 79
2025
Q2 		$52.2M Buy
756,419
+191,267
+34% +$12.5M 0.23% 80
2025
Q1 		$38.3M Buy
565,152
+311,098
+122% +$18.6M 0.19% 108
2024
Q4 		$11.2M Sell
254,054
-800
-0.3% -$44.9K 0.05% 264
2024
Q3 		$16M Sell
254,854
-581
-0.2% -$33.9K 0.07% 209
2024
Q2 		$15.1M Buy
255,435
+5,300
+2% +$332K 0.07% 206
2024
Q1 		$20M Sell
250,135
-21,467
-8% -$1.64M 0.1% 188
2023
Q4 		$21.4M Sell
271,602
-69,147
-20% -$4.92M 0.12% 161
2023
Q3 		$23.8M Sell
340,749
-31,663
-9% -$2.24M 0.16% 134
2023
Q2 		$25.7M Sell
372,412
-29,335
-7% -$2.09M 0.17% 121
2023
Q1 		$29.9M Sell
401,747
-246,970
-38% -$20.7M 0.21% 106
2022
Q4 		$60.5M Sell
648,717
-85,470
-12% -$8.25M 0.45% 48
2022
Q3 		$70M Sell
734,187
-68,720
-9% -$6.8M 0.54% 42
2022
Q2 		$74.4M Buy
802,907
+344,458
+75% +$33.6M 0.55% 39
2022
Q1 		$46.4M Buy
458,449
+141,272
+45% +$14.8M 0.27% 78
2021
Q4 		$32.9M Sell
317,177
-52,820
-14% -$4.88M 0.17% 118
2021
Q3 		$31.4M Buy
369,997
+19,220
+5% +$1.61M 0.17% 132
2021
Q2 		$29.3M Sell
350,777
-6,395
-2% -$524K 0.18% 125
2021
Q1 		$26.9M Buy
357,172
+34,659
+11% +$2.52M 0.18% 122
2020
Q4 		$22M Sell
322,513
-3,406
-1% -$222K 0.15% 139
2020
Q3 		$19M Buy
325,919
+36,706
+13% +$2.28M 0.14% 148
2020
Q2 		$18.8M Buy
289,213
+47,014
+19% +$2.96M 0.15% 136
2020
Q1 		$14.4M Buy
242,199
+19,450
+9% +$1.3M 0.15% 140
2019
Q4 		$16.5M Sell
222,749
-12,100
-5% -$850K 0.13% 153
2019
Q3 		$14.8M Buy
234,849
+18,900
+9% +$1.12M 0.13% 155
2019
Q2 		$11.8M Sell
215,949
-228,400
-51% -$12.3M 0.1% 185
2019
Q1 		$24M Sell
444,349
-3,316,142
-88% -$205M 0.22% 98
2018
Q4 		$246M Sell
3,760,491
-127,781
-3% -$9.54M 2.21% 5
2018
Q3 		$306M Buy
3,888,272
+916,859
+31% +$65.5M 2.33% 6
2018
Q2 		$191M Buy
2,971,413
+2,851,421
+2,376% +$188M 1.63% 13
2018
Q1 		$7.46M Sell
119,992
-67,976
-36% -$4.88M 0.07% 173
2017
Q4 		$13.6M Buy
187,968
+5,580
+3% +$406K 0.12% 147
2017
Q3 		$14.8M Buy
182,388
+4,500
+3% +$356K 0.13% 139
2017
Q2 		$14.3M Sell
177,888
-3,845
-2% -$304K 0.14% 144
2017
Q1 		$14.3M Buy
181,733
+48
+0% +$3.83K 0.14% 130
2016
Q4 		$14.3M Buy
181,685
+1,431
+0.8% +$116K 0.17% 97
2016
Q3 		$16M Buy
180,254
+3,400
+2% +$321K 0.17% 100
2016
Q2 		$16.9M Sell
176,854
-3,269
-2% -$326K 0.19% 97
2016
Q1 		$18.7M Sell
180,123
-4,531
-2% -$441K 0.21% 89
2015
Q4 		$18.1M Buy
+184,654
New +$18.1M 0.23% 81

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s CVS Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of CVS Health (CVS) in Q1 2026, closing a stake of 833,771 shares — an estimated $66.2M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CVS in Q4 2015 and held it in 41 quarters. The position peaked at $306M in Q3 2018. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 833,771 CVS Health shares in Q1 2026, an estimated $66.2M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in CVS Health in Q4 2015 and held it in 41 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s CVS Health position peaked at $306M in Q3 2018.
  • 1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.